The U.S. Food and Drug Administration (FDA) recently released the sixth and final part of its year-long sampling assignment of testing talc-based cosmetics products for asbestos contamination, which was performed by an outside laboratory. Those testing services were performed by Lanham, Maryland-based AMA Analytical Services, Inc. (AMA) and commenced in September 2018. AMA was selected because of its expertise and knowledge in asbestos testing, as well as having conducted a previous successful survey for the FDA.
The FDA contracted AMA to test talc-based cosmetics products such as makeup and Johnson & Johnson’s Baby Powder, which were selected and purchased by the FDA and provided to the laboratory as blinded samples. During the course of its testing, AMA found that nine of the 43 samples provided tested positive for asbestos contamination, including one lot of Johnson & Johnson’s Baby Powder, which was recalled in October 2019. Other cosmetics products which tested positive for asbestos included makeup produced and sold by Claire’s and City Color, some of which have been recalled.
The FDA selected the various products based on criteria such as the type of talc-based product, range of price, prevalence on social media and other advertisements, whether it was marketed as a children’s product, and whether the FDA had received third-party reports of asbestos contamination in the particular product. AMA’s testing procedures utilized Polarized Light Microscopy (PLM) and Transmission Electron Microscopy (TEM) to detect and quantify mineral particles which were suspected to perhaps be asbestos fibers. According to the FDA, TEM is the most sensitive testing method for detecting and quantifying asbestos minerals.